Need of Epigenetic Biomarkers

    The epigenome describes to the complete description of all potentially heritable modifications of the genome without any changes in primary DNA sequences. Epigenetic biomarkers can be widely defined as measurable modifications of the genome with preserved DNA sequence.

    Epigenetic manupulation and regulators represent potential molecular elements which control relevant physiological and pathological features, thereby contributing to the natural history of human disease. These epigenetic modulators can be used as disease biomarkers, since they show several advantages and provide information about gene function, thus explaining differences among patient endophenotypes.

    Noninvasive Epigenetic Markers can be used as biomarkers for the molecular diagnosis of following cancer:

  • Prostate Cancer
  • Bladder Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Breast Cancer
  • Ovarian Cancer

Related Conference of Need of Epigenetic Biomarkers

August 22-23, 2019

5th International Congress on Epigenetics & Chromatin

Vienna, Austria
August 30-31, 2019

International Conference on Genetic Disorders

Bangkok, Thailand
September 13-14, 2019

12th World Congress on Cell & Tissue Science

Singapore
October 21-22, 2019

23rd European Biotechnology Congress

Zurich, Switzerland
November 26-27, 2019

International Conference On Genomics and Molecular Biology

Lisbon | Portugal
November 26-27, 2019

International Conference on Cell and Gene Therapy

| Lisbon, Portugal
February 24-25, 2020

24th Global Congress on Biotechnology

London, UK
March 16-17, 2020 |

12th World Congress and Expo on Cell & Stem Cell Research

Chicago, Illinois, USA
May 21-22, 2020

24th European Biotechnology Congress

London,UK

Need of Epigenetic Biomarkers Conference Speakers

Recommended Sessions

Related Journals

Are you interested in